Prognostic significance of CD26 in patients with colorectal cancer

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Lam, Colin Siu Chi ^a   Cheung, Alvin Ho Kwan ^a   Wong, Sunny Kit Man ^a   Wan, Timothy Ming Hun ^a   Ng, Lui ^a   Chow, Ariel Ka Man ^a   Cheng, Nathan Shiu Man ^a   Pak, Ryan Chung Hei ^a   Li, Hung Sing ^a   Man, Johnny Hon Wai ^a   Yau, Thomas Chung Cheung ^a   Lo, Oswens Siu Hung ^a   Poon, Jensen Tung Chung ^a   Pang, Roberta Wen Chi ^a   Law, Wai Lun ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, HUMAN;

AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE MARKER; DISTANT METASTASIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OVERALL SURVIVAL; PREDICTION; SURVIVAL RATE; ADULT; COLORECTAL NEOPLASMS; DIAGNOSTIC USE; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; NEOPLASM METASTASIS; PHYSIOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DIPEPTIDYL PEPTIDASE 4; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS;

EID: 84901630152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098582     Document Type: Article

References (35)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA: a cancer journal for clinicians 59: 225-249.
2. Hunter KW, Crawford NP, Alsarraj J (2008) Mechanisms of metastasis. Breast Cancer Res 10 Suppl 1: S2.
3. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 16: 481-488.
4. Mentlein R (1999) Dipeptidyl-peptidase IV (CD26) - role in the inactivation of regulatory peptides. Regulatory peptides 85: 9-24.
5. Tanaka T, Camerini D, Seed B, Torimoto Y, Dang NH, et al. (1992) Cloning and functional expression of the T cell activation antigen CD26. Journal of immunology 149: 481-486.
6. Wolf M, Albrecht S, Marki C (2008) Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int J Biochem Cell Biol 40: 1185-1198.
7. Bauvois B (1988) A collagen-binding glycoprotein on the surface of mouse fibroblasts is identified as dipeptidyl peptidase IV. The Biochemical journal 252: 723-731.
8. Piazza GA, Callanan HM, Mowery J, Hixson DC (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem J 262: 327-334. (Pubitemid 19220964)
9. Loster K, Zeilinger K, Schuppan D, Reutter W (1995) The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site. Biochemical and biophysical research communications 217: 341-348.
10. Gonzalez-Gronow M, Kaczowka S, Gawdi G, Pizzo SV (2008) Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor. Front Biosci 13: 1610-1618. (Pubitemid 351599720)
11. Havre PA, Abe M, Urasaki Y, Ohnuma K, Morimoto C, et al. (2008) The role of CD26/dipeptidyl peptidase IV in cancer. Front Biosci 13: 1634-1645. (Pubitemid 351599721)
12. Sedo A, Stremenova J, Busek P, Duke-Cohan JS (2008) Dipeptidyl peptidase-IV and related molecules: markers of malignancy? Expert Opin Med Diagn 2: 677-689. (Pubitemid 351997856)
13. Pang R, Law WL, Chu AC, Poon JT, Lam CS, et al. (2010) A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell stem cell 6: 603-615.
14. Ayude D, Paez de la Cadena M, Cordero OJ, Nogueira M, Ayude J, et al. (2003) Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer. Disease markers 19: 267-272. (Pubitemid 38859472)
15. de la Haba-Rodriguez J, Macho A, Calzado MA, Blazquez MV, Gomez MA, et al. (2002) Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma. Neoplasma 49: 307-311.
16. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16: 481-488. (Pubitemid 40458328)
17. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. The New England journal of medicine 328: 1365-1371. (Pubitemid 23131388)
18. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467-1471. (Pubitemid 26400241)
19. Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, et al. (2002) American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 52: 8-22. (Pubitemid 34110468)
20. Vijan S, Hwang EW, Hofer TP, Hayward RA (2001) Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 111: 593-601. (Pubitemid 34088068)
21. Winawer SJ (2005) Screening of colorectal cancer. Surgical oncology clinics of North America 14: 699-722.
22. Hakomori S (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52: 257-331.
23. Yamada K, Hayashi M, Madokoro H, Nishida H, Du W, et al. (2013) Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription. PloS one 8: e62304.
24. Hundt S, Haug U, Brenner H (2007) Blood markers for early detection of colorectal cancer: a systematic review. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16: 1935-1953.
25. Cordero OJ, Ayude D, Nogueira M, Rodriguez-Berrocal FJ, de la Cadena MP (2000) Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. British journal of cancer 83: 1139-1146.
26. Kirkland SC (2009) Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells. Br J Cancer 101: 320-326.
27. Inamoto T, Yamochi T, Ohnuma K, Iwata S, Kina S, et al. (2006) Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix. Clin Cancer Res 12: 3470-3477.
28. Sato T, Yamochi T, Aytac U, Ohnuma K, McKee KS, et al. (2005) CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299. Cancer research 65: 6950-6956. (Pubitemid 41060735)
29. Benoist S, Brouquet A, Penna C, Julie C, El Hajjam M, et al. (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24: 3939-3945. (Pubitemid 46630742)
30. Gold P, Freedman SO (1965) Demonstration of Tumor-Specific Antigens in Human Colonic Carcinomata by Immunological Tolerance and Absorption Techniques. J Exp Med 121: 439-462.
31. National Cancer Institute of Canada-American Cancer Society (1972) A collaborative study of a test for carcinoembryonic antigen (CEA) in the sera of patients with carcinoma of the colon and rectum. A joint National Cancer Institute of Canada-American Cancer Society investigation. Can Med Assoc J 107: 25-33.
32. Dhar P, Moore T, Zamcheck N, Kupchik HZ (1972) Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA 221: 31-35.
33. Lo Gerfo P, Lo Gerfo F, Herter F, Barker HG, Hansen HJ (1972) Tumor-associated antigen in patients with carcinoma of the colon. Am J Surg 123: 127-131.
34. Zamcheck N, Moore TL, Dhar P, Kupchik H (1972) Immunologic diagnosis and prognosis of human digestive-tract cancer: carcinoembryonic antigens. N Engl J Med 286: 83-86.
35. Herrera MA, Chu TM, Holyoke ED (1976) Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 183: 5-9.